Ancora Biotech Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Ancora Biotech LLC is a privately held biotechnology research company based in Palo Alto, California, that supports the clinical development of three multi-specific antibody programs. These programs are organized in separate spin-offs, each pursuing a distinct therapeutic area. One program in clinical development centers on a T cell engager targeting CD19 and CD3 for B cell cancers; another is a preclinical enzyme inhibitor targeting CD38 for inflammatory and metabolic disorders in the elderly; a third is a preclinical T cell engager directed at HBV and CD3 for chronic hepatitis B. Ancora Biotech provides oversight of manufacturing and clinical development for these assets.
The company was formed by former executives and shareholders of Teneobio, including Lightspeed Venture Partners and Sutter Hill Ventures, to oversee development for these assets. Based in Palo Alto, it operates with a small team within the biotechnology research sector, focusing on advancing complex antibody therapies through early-stage development and manufacturing oversight.

Get verified Ancora Biotech emails free

Company overview Employee directory